Overview

Mechano Growth Factor (MGF) is a splice variant of Insulin-like Growth Factor-1 (IGF-1) that is naturally produced in response to mechanical stress on muscle tissue. Unlike systemic IGF-1, MGF is believed to act locally at the site of muscle damage or stress to promote tissue repair and growth.

Research indicates that MGF may play a crucial role in muscle adaptation to exercise and injury repair. The peptide is thought to be released during the early phases of muscle damage and may help initiate the repair process before transitioning to other growth factors for continued regeneration.

Regulatory Note: MGF is not approved for human use and is prohibited by WADA for competitive athletes.

Mechanism of Action

MGF appears to work through several pathways:

1. Local IGF-1 Receptor Activation: MGF binds to IGF-1 receptors in muscle tissue, initiating anabolic signaling cascades that promote protein synthesis and cell growth.

2. Satellite Cell Activation: Research suggests MGF may activate satellite cells, which are crucial for muscle repair and growth by providing new nuclei to damaged muscle fibers.

3. Anti-apoptotic Effects: Studies indicate MGF may help prevent programmed cell death in damaged tissues, preserving more viable cells for repair.

4. Enhanced Protein Synthesis: Through mTOR pathway activation, MGF may stimulate increased protein production necessary for tissue repair and growth.

Research Summary

Limited research exists on MGF, with only 3 relevant animal studies identified in the literature search. No human clinical trials specifically targeting MGF have been completed.

Key Studies

Tendon Healing (2016) A study in Biotechnology Letters examined MGF E peptide in rat tendon injury models. Results suggested accelerated healing with improved collagen organization and reduced inflammatory markers compared to controls.

Bone Defect Healing (2011) Research published in International Orthopaedics investigated MGF E peptide in rabbit bone defect models. The study indicated enhanced osteoblast proliferation and improved bone healing compared to control groups.

Muscle Hypertrophy Reviews (2018) A comprehensive review in The Physician and Sportsmedicine discussed the role of various growth factors, including MGF, in muscle adaptation to exercise and mechanical stress.

Clinical Trial Landscape

No specific clinical trials for MGF as a therapeutic peptide were identified. Related trials focus on broader IGF-1 system components or growth factors in general.

Dosage Guidelines

No established human dosing protocols exist for MGF. The peptide remains in preclinical research phases.

Research dosing in animal studies has varied significantly and cannot be directly extrapolated to humans without proper clinical validation.

Safety Profile

Due to the lack of human studies, the safety profile of MGF remains largely unknown. Theoretical concerns include:

Potential Risks:

• Unknown effects on glucose metabolism
• Possible tumor growth promotion
• Unpredictable growth factor interactions
• Local injection site reactions

Monitoring Considerations:

• Blood glucose levels
• Cancer screening markers
• Growth factor hormone panels
• Local injection site assessment

Contraindications: Absolute contraindications include active malignancy, pregnancy/breastfeeding, and age under 18. Relative contraindications include diabetes and other endocrine disorders.

Stacking

Given the experimental nature of MGF, stacking with other compounds is not recommended outside of controlled research settings.

Theoretical Considerations:

• Combining with other IGF-1 variants may produce unpredictable effects
• Growth hormone combinations could amplify unknown risks
• Insulin interactions may complicate glucose management

Research Protocol Approach: Any research involving MGF should follow strict protocols with appropriate monitoring and safety measures in place.

References

1. The role of hormones in muscle hypertrophy. (2018). The Physician and sportsmedicine. DOI PubMed
2. Nutrition and growth in children. (2020). Minerva pediatrica. DOI PubMed
3. Preface. (2018). Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. DOI PubMed
4. Mechano-growth factor E peptide promotes healing of rat injured tendon. (2016). Biotechnology letters. DOI PubMed
5. Mecasermin. (2008). BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. DOI PubMed
6. The AR/miR-221/IGF-1 pathway mediates the pathogenesis of androgenetic alopecia. (2023). International journal of biological sciences. DOI PubMed
7. Mechano-growth Factor Expression in Colorectal Cancer Investigated With Fluorescent Gold Nanoparticles. (2019). Anticancer research. DOI PubMed
8. Mechano growth factor E peptide promotes osteoblasts proliferation and bone-defect healing in rabbits. (2011). International orthopaedics. DOI PubMed
9. Low Insulin-Like Growth Factor-1 Levels Are Associated With Myocardial Mechano-Energetic Efficiency in Older Individuals. (2025). The Journal of clinical endocrinology and metabolism. DOI PubMed
10. Acromegaly. (2019). Nature reviews. Disease primers. DOI PubMed